ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Guillemot Corp

Guillemot Corp (GUI)

5.24
-0.04
(-0.76%)
Closed September 25 11:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
5.24
Bid
5.00
Ask
5.30
Volume
420
5.20 Day's Range 5.32
4.405 52 Week Range 7.48
Market Cap
Previous Close
5.28
Open
5.32
Last Trade
2
@
5.24
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
4,975
Shares Outstanding
15,087,480
Dividend Yield
-
PE Ratio
83.26
Earnings Per Share (EPS)
0.06
Revenue
119.37M
Net Profit
964k

About Guillemot Corp

Sector
Computer Peripheral Eq, Nec
Industry
Computer Peripheral Eq, Nec
Headquarters
Vannes, Morbihan, Fra
Founded
-
Guillemot Corp is listed in the Computer Peripheral Eq sector of the Euronext with ticker GUI. The last closing price for Guillemot was 5.28 €. Over the last year, Guillemot shares have traded in a share price range of 4.405 € to 7.48 €.

Guillemot currently has 15,087,480 shares outstanding. The market capitalization of Guillemot is 79.66 € million. Guillemot has a price to earnings ratio (PE ratio) of 83.26.

GUI Latest News

Electronic Arts Says Revenue Up, Raises Outlook

Electronic Arts Inc. reported a jump in quarterly revenue and nudged up its full-year outlook for revenue and profit, saying it anticipates other videogame publishers will issue fewer competing...

Vivendi Refrains From Seeking Ubisoft Board Representation

PARIS--French billionaire Vincent Bolloré has refrained from seeking representation on Ubisoft Entertainment SA's board at a meeting of the videogame maker's shareholders on...

Vivendi Boosts Stake in Videogame Firm Ubisoft

Vivendi SA again boosted its stake in videogame firm Ubisoft Entertainment SA, and said it is considering further increases, increasing pressure on the Guillemot family that runs the company. The...

Vivendi Raises Its Stake in Ubisoft

Vivendi SA increased the pressure on videogame company Ubisoft Entertainment SA, adding to its stake and saying that it intends to continue buying more, according to a regulatory filing on Friday...

Vivendi Succeeds in Gameloft Takeover

PARIS—The Guillemot family said Tuesday it would sell the bulk of its shares in videogame developer Gameloft SE to Vivendi SA, pushing the French media company a step closer to rebuilding...

Vivendi Wins Majority Backing in Hostile Bid for Gameloft

PARIS—Vivendi SA appears to have prevailed in its efforts to gain control of Gameloft SE, pushing further into videogames after re-entering the sector last year. The French media group has...

Vivendi Buys Back into Videogame Business

PARIS—Vivendi SA is re-entering the videogame business, splashing out €160 million ($183 million) to buy stakes in French game publishers Ubisoft Entertainment SA and Gameloft SE. The...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.11.945525291835.145.36512615.26908139DE
4-0.42-7.420494699655.665.764.9634165.27382337DE
12-0.66-11.1864406785.96.44.949755.63727037DE
260.5211.01694915254.727.484.5595976.02967381DE
52-1.06-16.82539682546.37.484.40580735.97573648DE
156-6.36-54.827586206911.616.84.4051675511.39185032DE
2602.71107.1146245062.5318.551.296293789.02600298DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
INAInapa Inv Part Gestao
0.0056 €
(64.71%)
11.37M
ALKALKALRAY SA
2.795 €
(30.00%)
486.8k
MLEDUEduniversal
0.25 €
(25.00%)
1.1k
ALDVAlliance Developpement Capital Siic
0.0745 €
(23.14%)
51
MLCMGCMG Clean Tech
1.20 €
(20.00%)
2.27k
ALCYBCybergun
0.0001 €
(-50.00%)
14.22M
ALREARealites
3.40 €
(-34.36%)
14.71k
MLCOTCoretech 5
0.0155 €
(-26.19%)
555
ALAVEAventador
0.0028 €
(-22.22%)
10.79M
ALRPDRapid Nutrition
0.037 €
(-20.26%)
5.16M
LOCALSolocal Groupe
0.0029 €
(0.00%)
36.53M
BCPBanco Comercial Portugues SA
0.4045 €
(-0.44%)
35M
ALHPIHopium SA
0.016 €
(-13.98%)
15.11M
ALCYBCybergun
0.0001 €
(-50.00%)
14.22M
INAInapa Inv Part Gestao
0.0056 €
(64.71%)
11.37M

Discussion

View Full Feed
flipper44 flipper44 2 minutes ago
BTW: Yescarta
The FDA updated the approval for Yescarta (axicabtagene ciloleucel) in April 2022 to allow it to be used as a second-line treatment. This was the first time a CAR T-cell therapy was approved for use as a second-line treatment.

In other words, not SOC.
NWBO
BIOCHEMUP BIOCHEMUP 2 minutes ago
10K 0.002
10K 0.0004
RSPI
TrendTrade2016 TrendTrade2016 2 minutes ago
TGRP GETTING SMOKED...WARNED
TGRP
gfp927z gfp927z 2 minutes ago
>>> Acurx Announces Results of Its Pioneering Research with Ibezapolstat in Collaboration with Leiden University Medical Center at the Premier International C. difficile Symposium


PR Newswire

September 24, 2024


https://finance.yahoo.com/n
ACXP
RIGATONI RIGATONI 2 minutes ago
Looks like they recently terminated their offering...

RAADR, INC. (Form: 1-Z, Received: 09/17/2024 12:39:42) (otcmarkets.com)


certifies that it meets all of the conditions for termination of Regulation A reporting specified in
jedijazz jedijazz 2 minutes ago
$XXII BIG NEWS: $XXII 22nd Century Continues CMO Business Expansion with Additional Filtered Cigar Volume
CMO customer adds to previously announced cigarette export business with combined volume significantly adding to profitability

Mocksville, North Carolina--(Newsfile Corp. -
XXII
jedijazz jedijazz 3 minutes ago
$XXII BIG NEWS: $XXII 22nd Century Continues CMO Business Expansion with Additional Filtered Cigar Volume
CMO customer adds to previously announced cigarette export business with combined volume significantly adding to profitability

Mocksville, North Carolina--(Newsfile Corp. -
XXII
Monksdream Monksdream 3 minutes ago
FAAS 10 day hourly
https://investorshub.advfn.com/uimage/uploads/2024/9/25/gwcrrIMG_2125.gif
FAAS
Petroleum2024 Petroleum2024 3 minutes ago
What did hkd do? What's your price target for xhg? Thanks
XHG
Rainer Rainer 3 minutes ago
nice volume
RDAR
MartinLutherKing MartinLutherKing 3 minutes ago
Go big or go home
RNAZ
misanthrope misanthrope 3 minutes ago
What are your expectations?

Regarding financials, don't expect any until the next annual report is due - BIEL no longer files quarterly reports. Regarding news - there likely isn't anything KW is willing or able to report. She has stated when she has news that she can release she
BIEL
DawgTrading DawgTrading 3 minutes ago
Ill take a look around and hunt some down.
CBMJ
TRIPLE_ZERO_SEVEN TRIPLE_ZERO_SEVEN 3 minutes ago
Claims that it's hidden and the TA doesn't even know about it yet. He also claims inside information of a 1 for 2000 reverse split coming. Been claiming these things for at least a year now.
AAPJ
learningcurve2020 learningcurve2020 3 minutes ago
Btw, I hope I'm wrong in this one because I thought their T product was on the right track. But it feels to me like everything is being gutted.
MRKR
nyt nyt 3 minutes ago
They must've reconsidered... lololol

Some here sound as tho they're
HYPNOTIZED
VPLM
MartinLutherKing MartinLutherKing 3 minutes ago
RNAZ On the nasdaq big time brother,
RNAZ
ElectricJester54 ElectricJester54 3 minutes ago
I don't imagine it will hit a dollar off the bat from what I have read from other posts on here, maybe a couple years from now as the merging business grows and gains more attention. I think the realistic figures I have seen if I receall correctly are around like 0.25 per share, which is still a ton
ZHUD
double_m double_m 3 minutes ago
Good question, but I doubt it. If you follow the cycle, he usually gets issued his shares towards the bottom of the price fall off, and some time before announcing a SH meeting via 14A. Those shares are used to control the vote and aren't sold until after the RS. It's a continuous cycle. If you reme
MULN
docsetc docsetc 4 minutes ago
With Chandra's evasive and dispassionate answers today on 'X', I'm inclined to agree on all points. He could actually be uniting all shareholders, patient and incensed right now, for a huge Adnexus launch, but so far nothing that even remotely resembles true leadership or shareholder interests from
ENZC
TrendTrade2016 TrendTrade2016 4 minutes ago
OUCH...YOU WERE WARNE ABOUT THE TOP RINSE...RUG PULL WITH NO WEEKLY TREND
MONI
blackhawks blackhawks 4 minutes ago
But she doesn't lie more than the Orange Felon so, as usual, no f'ing point for you.
alwayswatching1 alwayswatching1 4 minutes ago
We are all amariaddicts. Otherwise why in the world would any of us still be here. Except of course our beloved paid bashers and those bitter souls who sold for epic losses.
AMRN
manibiotech manibiotech 4 minutes ago
In 2023, several cancer and oncology drugs were approved by the FDA. Here are some notable examples:

1. **Epkinly (epcoritamab-bysp)**
Approved on May 19, 2023, Epkinly is used to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymp
NWBO
oldman69 oldman69 4 minutes ago
Good job trading 101!
DJT

Your Recent History

Delayed Upgrade Clock